Form 4 for GILD Gilead Sciences
Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-09 · accession 0001127602-23-009787 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-10 | 2023-03-09 | GILD | Lofton Kevin E | Dir | M - OptEx | $52.38 | +8,442 | 8,442 | New | +$442.2K |
| D | 2023-03-10 | 2023-03-09 | GILD | Lofton Kevin E | Dir | M - OptEx | $0.00 | -8,442 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-09 | M | A | 8,442 | $52.38 | 8,442 | D | — | — | |
| 2 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-03-09 | M | D | 8,442 | $0.00 | 0 | D | $52.38 · — to 2023-05-08 | 8,442 Common Stock | (F1) Options vest quarterly over the first year of service upon the earlier of May 8, 2014, or the day immediately preceding the next regular annual stockholders meeting. |